TRISALUS LIFE SCIENCES INC COM - Stock (MTAC)

CUSIP: 58507N105

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / Stock
Total 13F shares
14,404,623
Share change
+1,442,910
Total reported value
$139,937,000
Price per share
$9.70
Number of holders
53
Value change
+$14,028,063
Number of buys
27
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 58507N105?
CUSIP 58507N105 identifies MTAC - TRISALUS LIFE SCIENCES INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TRISALUS LIFE SCIENCES INC COM - Stock (MTAC) as of Q2 2021

As of 30 Jun 2021, TRISALUS LIFE SCIENCES INC COM - Stock (MTAC) was held by 53 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,404,623 shares. The largest 10 holders included BlackRock Inc., Park West Asset Management LLC, ARISTEIA CAPITAL LLC, MARSHALL WACE, LLP, Linden Advisors LP, Polar Asset Management Partners Inc., CITADEL ADVISORS LLC, SPRING CREEK CAPITAL LLC, Radcliffe Capital Management, L.P., and MYDA Advisors LLC. This page lists 53 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.